Volitionrx (VNRX) Depreciation & Amortization (CF) (2011 - 2025)
Volitionrx (VNRX) posted Depreciation & Amortization (CF) of $230824.0 for Q4 2025, down 7.02% on a QoQ basis from $248253.0 in Q3 2025, and down 21.92% year-over-year from $295642.0 in Q4 2024.
Volitionrx (VNRX) Depreciation & Amortization (CF) (2011 - 2025) Analysis & Trends
Volitionrx's Depreciation & Amortization (CF) history runs 15 years deep, the most recent figure standing at $230824.0 for Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 21.92% year-over-year to $230824.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $983706.0 (down 11.63% YoY) and the FY2025 annual result came in at $983706.0, down 11.63% from the prior year.
- Depreciation & Amortization (CF) was $230824.0 for Q4 2025 at Volitionrx, down from $248253.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $296587.0 in Q4 2023 and bottomed at $224310.0 in Q1 2022.
- A 5-year average of $256543.8 and a median of $250454.5 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) soared 42.7% — and 2025, when it retreated 21.92%.
- Volitionrx's Depreciation & Amortization (CF) stood at $236847.0 in 2021, then advanced by 5.12% to $248968.0 in 2022, then climbed by 19.13% to $296587.0 in 2023, then retreated by 0.32% to $295642.0 in 2024, then slipped by 21.92% to $230824.0 in 2025.
- Business Quant data shows VNRX's Depreciation & Amortization (CF) at $230824.0 in Q4 2025, $248253.0 in Q3 2025, and $252688.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 67.10 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Volitionrx | 97,069.35 | -1.02 Mn | - | 230,824.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 230,824.00 |
| Dec 31, 2025 | 230,824.00 |
| Sep 30, 2025 | 248,253.00 |
| Sep 30, 2025 | 248,253.00 |
| Jun 30, 2025 | 252,688.00 |
| Jun 30, 2025 | 252,688.00 |
| Mar 31, 2025 | 251,941.00 |
| Mar 31, 2025 | 251,941.00 |
| Dec 31, 2024 | 295,642.00 |
| Dec 31, 2024 | 295,642.00 |
| Sep 30, 2024 | 285,038.00 |
| Sep 30, 2024 | 285,038.00 |
| Jun 30, 2024 | 269,297.00 |
| Jun 30, 2024 | 269,297.00 |
| Mar 31, 2024 | 263,207.00 |
| Mar 31, 2024 | 263,207.00 |
| Dec 31, 2023 | 296,587.00 |
| Dec 31, 2023 | 296,587.00 |
| Sep 30, 2023 | 295,634.00 |
| Sep 30, 2023 | 295,634.00 |